TITLE

TREATMENT OF ANGINA PECTORIS WITH A NEW CORONARY VASODILATOR, ISOSORBIDE DINITRATE SUBLINGUAL (ISORDIL SUBLORAL)

AUTHOR(S)
Smith Sr., Arthur L.
PUB. DATE
September 1962
SOURCE
Angiology;Sep1962, Vol. 13 Issue 9, p425
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the use of the coronary vasodilator, isosorbide dinitrate sublingual, for treatment of angina pectoris. Clinical features of angina pectoris; Safety and efficacy of the drug; Recommended dosage for oral isosorbide dinitrate treatment.
ACCESSION #
16370099

 

Related Articles

  • STUDIES ON A NEW CORONARY VASODILATOR; l-CHLORO-2,3-PROPANEDIOL DINITRATE. Burgison, Raymond M.; Lu, Gordon G.; Cowley, R. Adams; Krantz Jr., John C. // Angiology;Sep1962, Vol. 13 Issue 9, p412 

    Focuses on the development of a new coronary vasodilator, 1-chloro-2,3-propanediol dinitrate, for the treatment of angina pectoris. Capacity of the compound to provide a longer duration of vasodilation with less concomitant side-effects; Materials and methods for the development of the new...

  • Angeze SR.  // Royal Society of Medicine: Medicines;2002, p61 

    The article provides information on Angeze SR, is a proprietary, prescription-only preparation of the vasodilator drug isosorbide mononitrate. It can be used as an anti-angina drug, and is available as capsules.

  • Combination of Calcium Channel Blockers and Beta Blockers for Patients with Exercise-Induced Angina Pectoris: A Double-Blind Parallel-Group Comparison of Different Classes of Calcium Channel Blockers. van der Vring, J. A. F. M.; Daniëls, M. C. G.; Holwerda, N. J. H.; Withagen, P. J. A. M.; Schelling, A.; Cleophas, T. J.; Hendriks, M. G. C. // Angiology;Jun1999, Vol. 50 Issue 6, p447 

    The combination of calcium channel blockers and beta blockers is more effective for the treatment of exercise-induced angina pesters than beta blocker monotherapy. Since ischemia in exercise-induced angina is essentially preceded by an increase in heart rate, calcium channel blockers with...

  • Prinzmetal's angina.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1893 

    A reference entry for the medical term "Prinzmetal's angina," another word for variant angina, is presented.

  • Nitroglycerin Transdermal Patch.  // AHFS Consumer Medication Information;Sep2017, p1 

    Nitroglycerin transdermal patches are used to prevent episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). Nitroglycerin transdermal patches can only be used to prevent attacks of angina; they cannot be used...

  • Nitroglycerin Sublingual.  // AHFS Consumer Medication Information;Sep2017, p1 

    Nitroglycerin spray and tablets are used to treat episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). The spray and tablets may also be taken just before activities that may cause episodes of angina in order...

  • isosorbide mononitrate.  // Royal Society of Medicine: Medicines;2002, p311 

    The article presents information on isosorbide mononitrate, a short-acting vasodilator and anti-angina drug. It is used to prevent attacks of angina pectoris (ischaemic heart pain) when taken before exercise, during an acute attack and as an adjunct (to aid and assist) in heart failure...

  • Minitran.  // Royal Society of Medicine: Medicines;2002, p368 

    This article presents information on Minitran. It is a proprietary, non-prescription preparation of the vasodilator and anti-angina drug glyceryl trinitrate. It can be used to treat and prevent angina pectoris. The drug is available as a self-adhesive dressing patch from which, when placed on...

  • Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). Hjemdahl, P.; Eriksson, S. V.; Held, C.; Forslund, L.; Näsman, P.; Rehnqvist, N. // Heart;Feb2006, Vol. 92 Issue 2, p177 

    Objective: To evaluate the long term prognosis of patients with stable angina pectoris. Design: Registry based follow up (median 9.1 years) of patients participating in the APSIS (angina prognosis study in Stockholm), which was a double blind, single centre trial of antianginal drug treatment....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics